Dr. Andrea Small-Howard has more than 20 years of scientific research and executive experience in the biopharma industry supervising research & development, manufacturing, and quality control divisions in the US and China. Dr. Small-Howard has taken novel biological products from ideation through commercialization. She has been named an inventor on more than sixty patent applications, taken the lead in obtaining regulatory approvals from the U.S. Food and Drug Administration ("US FDA") and numerous international regulatory agencies, and orchestrated licensing deals.
Dr. Andrea Small-Howard
CSO of GB Sciences
Shaheen Lakhan, MD, PhD, FAAN, is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development. He is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital. As an expert in patient-empowering clinical development from drugs to devices, Dr. Lakhan is keen on transforming medicine and democratizing health care through digital therapeutics (Click Therapeutics).
Dr Shaheen Lakhan
Chief Medical Officer of Click Therapeutics
John Seman is a results oriented Pharmaceutical leader. With proven success in growing profitable revenue. expertise in: Strategic Leadership, Turnaround Expertise. Inspirational Communications, Operational Excellence, Global Business Development, Disciplined Financial Management
John J. Seman
CEO Revitale Pharma
Dr. Eyal S. Ron is a seasoned entrepreneur with a track record of leading successful start-ups from conception to exit. With over 30 years of experience in drug development, medical devices, drug eluting medical devices, cosmeceuticals, and nutraceuticals. Dr. Ron combines deep scientific expertise with innovative business strategies to accelerate value inflection points. He also serves on corporate boards and volunteers with mentoring organizations (Biodesign, MassChallenge, and Northestern’s VMN).